Saskia Zemolka

This inventor holds 12 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 15 EPO patents. Top assignees: Gruenenthal Gmbh, Grunenthal Gmbh. Active years: 2008-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Saskia Zemolka. Retrieved from https://idiyas.com/inventor/saskia-zemolka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 3)

CIPO Patents = 1

EPO Patents = 15 (Patent Applications = 8)

Average Co-Inventor Count = 6.5

ph-index = 5

Forward Citations = 74(Granted Patents)

Location History:

Constance, DE (2010)
Aachen, DE (2008 - 2013)

Company Filing History:

Years Active: 2008-2013

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8404740 - Spirocyclic cyclohexane compounds (2013-03-26),

2. 8399503 - Spirocyclic azaindole derivatives (2013-03-19),

3. 8357705 - Substituted cyclohexyldiamines (2013-01-22),

4. 8293758 - Substituted spirocyclic cyclohexane derivatives (2012-10-23),

5. 8288430 - Spiro(5.5)undecane derivatives (2012-10-16),

6. 8288406 - Hydroxymethylcyclohexylamines (2012-10-16),

7. 8138187 - Substituted heteroaryl derivatives (2012-03-20),

8. 8008304 - Substituted propiolic acid amides and their use for producing drugs (2011-08-30),

9. 7977370 - (Hetero)aryl cyclohexane derivatives (2011-07-12),

10. 7893069 - Substituted imidazo[2,1-b]thiazole compounds and uses thereof (2011-02-22),

11. 7696238 - Substituted benzo[d]isoxazol-3-yl amine compounds as analgesics (2010-04-13),

12. 7420056 - Substituted bicyclic imidazo-3-ylamine compounds (2008-09-02),

Title: The Innovative Contributions of Saskia Zemolka

Introduction

Saskia Zemolka is a prominent inventor based in Aachen, Germany. She has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. Her work focuses on developing novel compounds that have potential therapeutic applications.

Latest Patents

Among her latest patents are the spirocyclic cyclohexane compounds, which are designed for the treatment and inhibition of pain and other conditions mediated by the ORL-1 or the μ-opioid receptor. These compounds are characterized by specific structural formulas, where R, R', R'', and X have defined meanings. Additionally, she has developed spirocyclic azaindole derivatives, which include substituted azaindole derivatives and methods for their production. These derivatives are intended for use in medicaments, showcasing her commitment to advancing medical science.

Career Highlights

Saskia has worked with notable companies such as Grünenthal GmbH, where she has contributed her expertise in pharmaceutical innovation. Her career is marked by a dedication to research and development, leading to the creation of impactful medicinal compounds.

Collaborations

Throughout her career, Saskia has collaborated with esteemed colleagues, including Werner Guenter Englberger and Klaus Linz. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Saskia Zemolka's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to influence the development of new therapeutic solutions.

Profile summary based on public USPTO records.